Zweig Di Menna Associates LLC Sigilon Therapeutics, Inc. Transaction History

Zweig Di Menna Associates LLC

  • $951 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 25, 2021
SELL
$4.42 - $10.61 $523,787 - $1.26 Million
-118,504 Closed
0 $0
Q2 2021

Jul 29, 2021
BUY
$9.15 - $20.17 $140,031 - $308,681
15,304 Added 14.83%
118,504 $1.27 Million
Q1 2021

Apr 26, 2021
BUY
$18.76 - $40.91 $1.82 Million - $3.97 Million
97,000 Added 1564.52%
103,200 $2.31 Million
Q4 2020

Jan 26, 2021
BUY
$27.6 - $48.03 $171,120 - $297,786
6,200 New
6,200 $298,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email